기관지폐 이형성증에 대한 덱사메타손 구제 치료
Current Use of Dexamethasone Rescue Therapy for Bronchopulmonary Dysplasia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : The aim of this study is to investigate the current use of dexamethasone rescue therapy (DRT) for bronchopulmonary dysplasia (BPD). Methods : This is a retrospective study of 251 BPD patients managed in the neonatal intensive care units at Seoul National University Childrens Hospital and Seoul National University Bundang Hospital between March 2004 and August 2008. The demographic data and clinical characteristics of the mothers and infants were analyzed. The infants were compared based on DRT responsiveness. The DRT complications were investigated. Resluts : Ninety-three patients (37.1%) were classified with severe BPD, DRT was only given to patients with severe BPD. Dexamethasone was administered to 24 patients (9.6%) whose respiratory status had precluded extubation, which indicated that conventional BPD management had failed. Fourteen patients (58.3%) who received DRT were responsive. DRT non-responders required more oxygenation and more complicated with pulmonary arterial hypertension (PAH). Responder had shorter length's of hospitalization and lower mortality rates. High dose dexamethasone was no more effective in weaning neonates from the ventilatior than low dose dexamethasone. Sepsis was the most common complication of DRT. Conclusion : DRT is a valuable treatment for severe BPD ahead of PAH development. DRT should not be performed in BPD patients with PAH due to the possibility of complications.
Abstract
Purpose : The aim of this study is to investigate the current use of dexamethasone rescue therapy (DRT) for bronchopulmonary dysplasia (BPD). Methods : This is a retrospective study of 251 BPD patients managed in the neonatal intensive care units at Seoul National University Childrens Hospital and Seoul National University Bundang Hospital between March 2004 and August 2008. The demographic data and clinical characteristics of the mothers and infants were analyzed. The infants were compared based on DRT responsiveness. The DRT complications were investigated. Resluts : Ninety-three patients (37.1%) were classified with severe BPD, DRT was only given to patients with severe BPD. Dexamethasone was administered to 24 patients (9.6%) whose respiratory status had precluded extubation, which indicated that conventional BPD management had failed. Fourteen patients (58.3%) who received DRT were responsive. DRT non-responders required more oxygenation and more complicated with pulmonary arterial hypertension (PAH). Responder had shorter length's of hospitalization and lower mortality rates. High dose dexamethasone was no more effective in weaning neonates from the ventilatior than low dose dexamethasone. Sepsis was the most common complication of DRT. Conclusion : DRT is a valuable treatment for severe BPD ahead of PAH development. DRT should not be performed in BPD patients with PAH due to the possibility of complications.
참고문헌 (25)
- Roberts D, "Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth", Cochrane Database Syst Rev, 19(3), pp.CD004454~ (2006)
- Brownfoot FC, "Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth", Cochrane Database Syst Rev, 8(4), pp.CD004454~ (2008)
- Crowther CA, "Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease", Cochrane Database Syst Rev, 18(3), pp.CD003935~ (2007)
- Doyle LW, "DART study investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial", Pediatrics, 117, pp.75~83 (2006)
- Anderson PJ, "Neurodevelopmental outcome of bronchopulmonary dysplasia", Semin Perinatol, 30, pp.227~232 (2006)
- O'Shea TM, "Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age", Pediatrics, 104, pp.15~21 (1999)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
- Gattinoni L, "The concept of "baby lung"", Intensive Care Med, 31, pp.776~784 (2005)
- Mishra R, "Low-birth-weight neonates exhibit a physiological set-point to regulate CO2: an untapped potential to minimize volutrauma-associated lung injury", Am J Perinato, 20, pp.453~463 (2003)
- Goodman G, "Pulmonary hypertension in infants with bronchopulmonary dysplasia", J Pediatr, 112, pp.67~72 (1988)
- Khemani E, "Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era", Pediatrics, 120, pp.1260~1269 (2007)
- Papile LA, "A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants", New England Journal of Medicine, 338, pp.1112~1118 (1998)
- Wilson-Costello D, "Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants", Pediatrics, 123, pp.e430~e437 (2009)
- Gross SJ, "Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease", Pediatrics, 115, pp.681~687 (2005)
- Onland W, "Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo- controlled trials", Pediatrics, 123, pp.367~377 (2009)
- Watterberg KL, "Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants", Pediatrics, 120, pp.40~48 (2007)
- Jobe AH, "Postnatal corticosteroids for bronchopulmonary dysplasia", Clin Perinatol, 36, pp.177~188 (2009)
- Ng PC, "Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants", Neonatology, 94, pp.170~175 (2008)
- Jobe AJ, "The new BPD: an arrest of lung development", Pediatr Res, 46, pp.641~643 (1999)
- Charafeddine L, "Atypical chronic lung disease patterns in neonates", Pediatrics, 103, pp.759~765 (1999)
- Choi CW, "Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants", Pediatr Int, 47, pp.72~79 (2005)
- Bland RD, "Neonatal chronic lung disease in the post-surfactant era", Biol Neonate, 88, pp.181~191 (2005)
- Husain AN, "Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia", Hum Pathol, 29, pp.710~717 (1998)
- Speer CP, "Inflammation and bronchopulmonary dysplasia", Semin Neonatol, 8, pp.29~38 (2003)
- Haroon Parupia MF, "Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants", J Perinatol, 21, pp.242~247 (2001)